Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Abivax's IPO to fund HIV and hep B pipeline before potential Big Pharma deal

In France’s largest ever biotech IPO, Abivax has raised €58m ($64m) to continue developing its HIV and Hep B candidates.

Israel, Brazil added to list of countries with API GMP standards equivalent to EU

The European Commission last week officially added Israel and Brazil to a list of countries outside the EU that have standards of manufacture and supervision of APIs equivalent to those of the EU. 

GMP assessments should consider environmental impact say campaigners

A group calling for GMP assessments to consider the environmental impact of API production says pollution generated by suppliers in China is furthering the spread of resistant superbugs.

Canadian manufacturer hit with warning letter over cross-contamination issues

Toronto-based Attix Pharmaceuticals has received a US FDA warning letter after an inspection from November and a lack of corrective actions in the company’s response to the FDA.


Pharma appointments: who's going places in July

The latest senior jobs news from Voyager, Celgene, Synergy and more.

GSK back in China via new API manufacturing agreement with Desano

GSK’s HIV unit ViiV Healthcare and China-based Desano Pharmaceuticals have forged an agreement whereby Desano will manufacture the API of GSK’s HIV drug Tivicay (dolutegravir) in China.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...